116 related articles for article (PubMed ID: 9223386)
1. Statins and fibrates in the management of diabetic dyslipidemia.
Durrington P
Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
[No Abstract] [Full Text] [Related]
2. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
Martínez-Castelao A
Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
[No Abstract] [Full Text] [Related]
3. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
Landry P; Dimitri E; Tessier S; Légaré N
J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696
[No Abstract] [Full Text] [Related]
4. [Dyslipoproteinemia of diabetes: fibrates or statins?].
Moulin P
Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198
[No Abstract] [Full Text] [Related]
5. [Milestone in the treatment of diabetic dyslipidemia: the DAIS Study].
Forster T
Orv Hetil; 2001 Jul; 142(29):1588-9. PubMed ID: 11494751
[No Abstract] [Full Text] [Related]
6. [Is it necessary to systematically treat diabetics with statins?].
Vergès B
Journ Annu Diabetol Hotel Dieu; 2001; ():189-95. PubMed ID: 11565462
[No Abstract] [Full Text] [Related]
7. Treatment of lipids. Implications for the general practitioner.
Simons LA
Aust Fam Physician; 1996 Jul; 25(7):1053-9. PubMed ID: 8768271
[TBL] [Abstract][Full Text] [Related]
8. Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.
Athyros VG; Kakafika AI; Karagiannis A; Mikhailidis DP
Am J Cardiol; 2008 Jun; 101(11):1679-80. PubMed ID: 18489951
[No Abstract] [Full Text] [Related]
9. Management of patients with dyslipidaemia.
Mann J; Chisholm A; Crooke M; Jackson R; Neutze J; North D; Swinburn B; White H; Wilcox J
N Z Med J; 1995 Oct; 108(1010):444. PubMed ID: 7478355
[No Abstract] [Full Text] [Related]
10. Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety.
Shepherd J
Eur Heart J; 1995 Jan; 16(1):5-13. PubMed ID: 7737222
[No Abstract] [Full Text] [Related]
11. Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients.
de Lorgeril M; Boissonnat P; Salen P; Monjaud I; Dureau G
J Heart Lung Transplant; 1996 May; 15(5):539-40. PubMed ID: 8771511
[No Abstract] [Full Text] [Related]
12. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
Udawat H; Goyal RK
Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
[TBL] [Abstract][Full Text] [Related]
13. The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.
Dierkes J; Westphal S; Luley C
Expert Opin Drug Saf; 2004 Mar; 3(2):101-11. PubMed ID: 15006716
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation.
Vivekananthan K; Mehra MR; Uber PA; DeGruiter H; Lavie CJ; Milani RV
J Assoc Physicians India; 2002 May; 50(5):682-4. PubMed ID: 12186124
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-density-lipoprotein lowering with statins.
Seidel D; Cremer P
Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915367
[No Abstract] [Full Text] [Related]
16. Efficacy of low-density-lipoprotein lowering with statins.
Rosenson RS; Stein JH
Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915366
[No Abstract] [Full Text] [Related]
17. Managing dyslipidemia in adults with diabetes.
Haffner SM
Manag Care; 2003 Sep; 12(9 Suppl):10-5. PubMed ID: 14535130
[No Abstract] [Full Text] [Related]
18. Should we dismiss fibrates for the treatment of diabetic dyslipidaemia?
Taskinen MR
Nutr Metab Cardiovasc Dis; 2006 Dec; 16(8):509-12. PubMed ID: 17071064
[No Abstract] [Full Text] [Related]
19. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
[TBL] [Abstract][Full Text] [Related]
20. [New developments in the treatment of diabetes and hyperlipidemias].
Ducobu J
Rev Med Brux; 1998 Sep; 19(4):A379-85. PubMed ID: 9805978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
